Herpes zoster vaccination: Benefits and barriers

Journal of the American Osteopathic Association

Volumn 109, Issue 6 SUPPL. 2, 2009, Pages

  Komara, Francis A ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE;

CONFERENCE PAPER; DRUG APPROVAL; DRUG EFFICACY; DRUG MARKETING; DRUG STORAGE; FOOD AND DRUG ADMINISTRATION; GERIATRIC PATIENT; GROUPS BY AGE; HEALTH PROGRAM; HERPES ZOSTER; HUMAN; MEDICARE; PHYSICIAN; POSTHERPETIC NEURALGIA; REIMBURSEMENT; VACCINATION;

AGED; HEALTH SERVICES ACCESSIBILITY; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; INCIDENCE; MIDDLE AGED; RISK ASSESSMENT;

EID: 67650499653     PISSN: 00986151     EISSN: 00986151     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Harpaz R, Ortega-Sanchez IR ,Seward, JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1-30. Available at: http://www.cdc.gov/mmwr/preview /mmwrhtml/rr57e0515a1.htm?s-cid=rr57e0515-e. Accessed March 11, 2009.
2. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271-2284. Available at: http://content.nejm.org/cgi/content/full/352/22/2271. Accessed March 11, 2009.
3. Zostavax [package insert]. Whitehouse Station, NJ: Merck & Co, Inc; December 2008. Available at: http://www.merck.com/product/usa/pi-circulars /z/zostavax/zostavax-pi.pdf. Accessed March 11, 2009.
4. Kerzner B, Murray AV, Cheng E, Ifle R, Harvey PR, Tomlinson M, et al. Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older. J Am Geriatr Soc. 2007;55:1499-1507. (Pubitemid 47508516)
5. Data sheet: Zostavax. Whitehouse Station, NJ: Merck & Co, Inc; February 2009. Available at: http://www.medsafe.govt.nz/profs/datasheet/z/zosta vaxinj.htm. Accessed March 11, 2009.
6. Product features-Zostavax. Merck Vaccine Support Web site. Available at: https://www.merck vaccines.com/zostavaxProductPage-frmst.html. Accessed March 11, 2009.
7. Reimbursement codes-CPT codes. Merck Vaccine Reimbursement Support Center Web site. Available at: http://www.vaccinesupportservices .com/reimbursement- codes/index.aspx. Accessed March 11, 2009.
8. High KP. Overcoming barriers to adult immunization. J Am Osteopath Assoc. 2009;109(suppl 2):S25-S28.